Since linc‐ROR could function as a ceRNA sponge for miR‐194‐3p and downregulate its expression, we speculate that, through the linc‐ROR/miR‐194‐3p/MECP2 regulatory axis, linc‐ROR could downregulate mTOR levels to decrease angiogenesis and then decrease the sensitivity of breast cancer cells to rapamycin. The gene discussed is MECP2; the disease is breast carcinoma.